Health-care companies fell sharply as traders rotated into sectors more sensitive to changes in interest-rate policy.

British drugmaker GSK fell after analysts at brokerage UBS cut their rating on the company's shares, citing patent expiries and market saturation of major drugs.


 Write to Rob Curran at rob.curran@dowjones.com 

(END) Dow Jones Newswires

11-11-22 1718ET